salesforce.com inc. [NYSE: CRM] gained 2.79% or 6.01 points to close at $221.29 with a heavy trading volume of 5367226 shares. The company report on March 25, 2022 that Salesforce Changes Legal Name to Salesforce, Inc..
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Salesforce (NYSE: CRM), the global leader in CRM, today announced that, effective April 4, 2022, the company will change its legal name from salesforce.com, inc. to Salesforce, Inc. Shares of Salesforce common stock will continue to trade on the NYSE as CRM and under the same CUSIP/ISIN number.
ABOUT SALESFORCESalesforce, the global CRM leader, empowers companies of every size and industry to digitally transform and create a 360° view of their customers. For more information about Salesforce (NYSE: CRM), visit: www.salesforce.com.
It opened the trading session at $218.62, the shares rose to $222.155 and dropped to $216.77, the range by which the price of stock traded the whole day. The daily chart for CRM points out that the company has recorded -18.73% loss over the past six months. However, it is still -19.98% lower than its most recent low trading price.
If we look at the average trading volume of 7.38M shares, CRM reached to a volume of 5367226 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about salesforce.com inc. [CRM]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CRM shares is $294.61 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CRM stock is a recommendation set at 1.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wedbush have made an estimate for salesforce.com inc. shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on March 02, 2022. While these analysts kept the previous recommendation, UBS raised their target price from $210 to $225. The new note on the price target was released on March 02, 2022, representing the official price target for salesforce.com inc. stock. Previously, the target price had yet another drop from $350 to $300, while Stifel kept a Buy rating on CRM stock. On March 02, 2022, analysts decreased their price target for CRM shares from 340 to 300.
The Average True Range (ATR) for salesforce.com inc. is set at 8.35, with the Price to Sales ratio for CRM stock in the period of the last 12 months amounting to 8.39. The Price to Book ratio for the last quarter was 3.75, with the Price to Cash per share for the same quarter was set at 10.50. Price to Free Cash Flow for CRM in the course of the last twelve months was 42.05 with Quick ratio for the last quarter at 1.00.
Trading performance analysis for CRM stock
salesforce.com inc. [CRM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.41. With this latest performance, CRM shares gained by 5.11% in over the last four-week period, additionally sinking by -18.73% over the last 6 months – not to mention a rise of 5.38% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CRM stock in for the last two-week period is set at 58.30, with the RSI for the last a single of trading hit 63.24, and the three-weeks RSI is set at 54.45 for salesforce.com inc. [CRM]. The present Moving Average for the last 50 days of trading for this stock 211.30, while it was recorded at 214.54 for the last single week of trading, and 250.37 for the last 200 days.
salesforce.com inc. [CRM]: A deeper dive into fundamental analysis
salesforce.com inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.00 and a Current Ratio set at 1.00.
salesforce.com inc. [CRM]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CRM. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for salesforce.com inc. go to 15.13%.
An analysis of insider ownership at salesforce.com inc. [CRM]
There are presently around $168,855 million, or 79.80% of CRM stock, in the hands of institutional investors. The top three institutional holders of CRM stocks are: VANGUARD GROUP INC with ownership of 76,162,895, which is approximately 3.439% of the company’s market cap and around 3.10% of the total institutional ownership; FMR LLC, holding 66,888,356 shares of the stock with an approximate value of $14.4 billion in CRM stocks shares; and BLACKROCK INC., currently with $14.33 billion in CRM stock with ownership of nearly 2.759% of the company’s market capitalization.
1,398 institutional holders increased their position in salesforce.com inc. [NYSE:CRM] by around 47,449,106 shares. Additionally, 837 investors decreased positions by around 35,914,729 shares, while 227 investors held positions by with 700,988,248 shares. The mentioned changes placed institutional holdings at 784,352,083 shares, according to the latest SEC report filing. CRM stock had 303 new institutional investments in for a total of 6,454,637 shares, while 130 institutional investors sold positions of 6,700,762 shares during the same period.